Skip to main content
Mankind Pharma Limited logo

Mankind Pharma Limited — Investor Relations & Filings

Ticker · MANKIND ISIN · INE634S01028 LEI · 33580067G8AZ7S8NYA02 BSE.NS Manufacturing
Open in API
Filings indexed 397 across all filing types
Latest filing 2024-12-19 Capital/Financing Update
Country IN India
Listing BSE.NS MANKIND

About Mankind Pharma Limited

https://www.mankindpharma.com/

Mankind Pharma Limited focuses on the development, manufacturing, and marketing of a broad spectrum of pharmaceutical formulations and consumer healthcare products. The company’s portfolio spans various therapeutic areas, including anti-infectives, cardiovascular, gastrointestinal, dermatology, and respiratory health. It maintains a significant presence in the over-the-counter segment with brands such as Manforce, Prega News, and Gas-O-Fast. The organization operates a robust research and development infrastructure dedicated to creating affordable and accessible medicinal solutions. Its operational model leverages an extensive distribution network to ensure product availability across diverse geographic regions, prioritizing high-quality healthcare delivery and patient-centric innovation.

Recent filings

Filing Released Lang Actions
Qualified Institutional Placement
Capital/Financing Update Classification · 95% confidence The document is a formal communication dated December 19, 2024, from Mankind Pharma Limited to stock exchanges regarding a Qualified Institutions Placement (QIP) of equity shares. It details the closure of the issue period, allocation of shares, issue price, and regulatory compliance under SEBI ICDR Regulations and Companies Act. The content focuses on fundraising activities and capital issuance, not on financial results, management changes, or voting outcomes. The document length is 3432 characters, which is relatively short but contains substantive information about the capital raising event rather than just announcing a report publication. Therefore, it fits best under Capital/Financing Update (CAP).
2024-12-19 English
Qualified Institutional Placement
Capital/Financing Update Classification · 95% confidence The document is a formal communication from Mankind Pharma Limited to stock exchanges regarding a Qualified Institutions Placement (QIP) of equity shares. It details the approval of the Board and Fund Raising Committee for raising funds through issuance of equity shares, fixing the floor price, and opening the issue. The document includes certified true copies of resolutions passed by the Fund Raising Committee authorizing the issue and price fixation. There are no financial statements or detailed financial performance data presented; rather, it is an announcement of a capital raising event and related approvals. This fits the category of Capital/Financing Update (CAP), as it concerns fundraising activities and capital structure changes. The document length and detail confirm it is not a mere announcement of a report (RPA) or a regulatory filing (RNS).
2024-12-16 English
General Updates
Regulatory Filings
2024-12-16 English
General Updates
Regulatory Filings Classification · 95% confidence The document is an official communication dated December 12, 2024, addressed to stock exchanges (BSE and NSE) regarding an order received from a tax authority (CGST) under the Central Goods and Services Tax Act, 2017. It discloses details of the order, the company's view on the order, and the intended appeal. The document references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is a regulatory announcement informing the market about a legal/tax matter and the company's response, without containing financial statements or detailed financial analysis. The document length is 3569 characters, relatively short and focused on disclosure. It does not contain financial results, management discussion, or audit information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures that do not fit other specific categories.
2024-12-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated December 4, 2024, addressed to stock exchanges regarding the company's management participation in upcoming investor meetings. It explicitly states that no unpublished price sensitive information will be disclosed and that discussions will be based on publicly available information. The document is an intimation or announcement about the management's participation in investor meetings, not the meeting materials or a transcript. It is brief (1492 characters) and serves as a regulatory disclosure under SEBI Listing Obligations. There is no financial data, report, or detailed presentation included. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance disclosure.
2024-12-04 English
Change in Company Secretary/Compliance Officer
Regulatory Filings Classification · 95% confidence The document is a formal announcement dated December 3, 2024, from Mankind Pharma Limited addressed to stock exchanges (BSE and NSE). It reports the outcome of a Board Meeting held on the same day. The key points include approval of disposal of a partnership interest and appointment of a new Company Secretary and Compliance Officer. The document includes detailed disclosures as per SEBI Listing Obligations and Disclosure Requirements Regulations 2015, which are typical for material events or corporate actions. The content focuses on corporate governance changes and material event disclosures rather than financial results or detailed reports. There is no indication of full financial statements or comprehensive management discussion. The document is not a report itself but an official announcement of board decisions and related disclosures. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance disclosures that do not fit other specific categories.
2024-12-03 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.